摘要
目的:观察经皮冠状动脉介入在冠心病患者中的应用效果。方法:选取2023年1月—2024年1月于道真仡佬族苗族自治县人民医院接受治疗的冠心病患者96例为研究对象,采用数字单双号法分为对照组与试验组,各48例。对照组行常规药物治疗,试验组在对照组基础上采用经皮冠状动脉介入治疗。比较两组心功能指标、治疗效果、心脏不良事件发生情况。结果:治疗后,两组左室射血分数、每搏输出量、心输出量高于治疗前,左室收缩末期内径、左室舒张末期内径低于治疗前,试验组左室射血分数、每搏输出量、心输出量高于对照组,左室收缩末期内径、左室舒张末期内径低于对照组,差异有统计学意义(P<0.05);试验组治疗总有效率高于对照组,差异有统计学意义(P=0.027);试验组心脏不良事件发生率低于对照组,差异有统计学意义(P=0.022)。结论:在常规药物治疗基础上联用经皮冠状动脉介入治疗冠心病的效果较好,可以改善心功能,减少心脏不良事件。
Objective:To observe the effect of percutaneous coronary intervention in patients with coronary heart disease.Methods:A total of ninety-six patients with coronary heart disease who received treatment in Daozhen Gelao Miao Autonomous County People's Hospital from January 2023 to January 2024 were selected as the study objects,and were divided into control group and experimental group by odd-even number method,with forty-eight cases in each group.The control group received conventional drug treatment,and the experimental group received percutaneous coronary intervention on the basis of the control group.The indexes of cardiac function,therapeutic effect and incidence of cardiac adverse events were compared between the two groups.Results:After treatment,left ventricular ejection fraction,stroke output and cardiac output were higher than before treatment,and left ventricular end-systolic diameter and left ventricular end-diastolic diameter were lower than before treatment,left ventricular ejection fraction,stroke output and cardiac output in experimental group were higher than those in control group,and left ventricular end-systolic diameter and left ventricular end-diastolic diameter in experimental group were lower than those in control group,the difference was statistically significant(P<0.05);the total effective rate of experimental group was higher than that of control group,the difference was statistically significant(P=0.027);the incidence of cardiac adverse events in experimental group was lower than that in control group,and the difference was statistically significant(P=0.022).Conclusion:Percutaneous coronary intervention on the basis of conventional drug therapy has a good effect on coronary heart disease,which can improve cardiac function and reduce cardiac adverse events.
作者
冯进
Feng Jin(Department of Cardiovascular,Zunyi Daozhen Gelao Miao Autonomous County People's Hospital,Zunyi 563500,Guizhou Province,China)
出处
《中外医药研究》
2024年第15期51-53,共3页
JOURNAL OF CHINESE AND FOREIGN MEDICINE AND PHARMACY RESEARCH
关键词
冠心病
经皮冠状动脉介入
心脏不良事件
Coronary heart disease
Percutaneous coronary intervention
Cardiac adverse events
